F32 F40 F41 F33 F34.1
Conditions
Interventions
Group 1: Interventiongroup: Process-based therapy (Questionnaire input three times per day for 4 weeks
One session per week for 24 weeks)
Group 2: Controlgroup: Guideline Psychotherapy (One session per week for 24 weeks)
Sponsors
Phillips-Universität
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: The subjects should be willing to participate in outpatient psychotherapy once a week for at least 24 weeks in the respective practice of the participating therapist. For the purpose of the study diagnostics, they have a smartphone and are willing to answer short electronic questionnaires several times a day for at least 4 weeks. You meet the criteria of a depressive disorder or an anxiety disorder. At the start of the study, you are either not receiving any psychiatric medication or your psychiatric medication has been consistent for at least 4 weeks at the start of the study. Due to the transdiagnostic approach, no stricter diagnostic inclusion criteria will be formulated.
Exclusion criteria
Exclusion criteria: Acute danger to self or others or a suicide attempt in the last six months. Ongoing psychotherapeutic treatment. Current substance dependence, bipolar I disorder (lifetime), psychotic disorder (lifetime), post-traumatic stress disorder, emotionally unstable personality disorder, severe physical illness or mental disorder requiring treatment in another setting (e.g., BMI<18.5, acute psychosis, brain organic disease).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. The treatment received by the intervention group is feasible. [Evidence of treatment feasibility: at least 70% of participants complete 70% of the intervention] 2. The treatment is accepted by the practitioners 3. The treatment is accepted by the patients 4. Patients' mental health will be significantly higher in the intervention group after treatment than before treatment 5. The mental health (PMH) of the patients after treatment will have increased significantly more in the intervention group than the mental health of the patients in the control group. 6. The mental health (PMH) of the patients will be significantly higher in the intervention group 6 months after treatment than before the start of treatment. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Depression and anxiety symptoms will be significantly lower in the intervention group after treatment than before treatment. 2. Depression and anxiety symptoms will be significantly lower in the intervention group after treatment than in the control group. 3. 6 months after treatment, depression and anxiety symptoms will be significantly lower in the intervention group than before treatment. 4. Quality of life, sense of well-being, acceptance, ability to reflect and functional inner processes will be significantly higher in the intervention group after treatment than before treatment. 5. Quality of life, well-being, acceptance, ability to reflect and functional inner processes will be significantly higher in the intervention group after treatment than in the control group. 6. Quality of life, well-being, acceptance, ability to reflect and functional inner processes will be significantly higher in the intervention group 6 months after treatment than before treatment. | — |
Countries
Germany
Contacts
Public ContactUlrich Stangier
Goethe-Universität
Outcome results
None listed